A general data-base comprising the capacity of all commercial lysis buffers, thermal treatments, as well as in house inactivation methods used at each institute or facility should be set up in order to share the viral or bacterial inactivation data generated from each validation test, and to ultimately save money and invest in common inactivation strategies. In overview, the removal of inactivated samples from a BSL3 facility must be limited at a minimum, and avoided entirely whenever possible. Although the BSL3/4 environment is highly expensive, it is necessary to find ways to perform the majority of activities with BSL3 pathogens inside a BSL3/4 facility. Clearly, the higher the number of inactivated biological samples reaching the outside of BSL3 facilities, the more likely a potentially dangerous situation may arise.
Xavier Abad; Transfer of Biological Samples from a Biosafety Level 3 Facility
OMICS Group through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. It follows an Open Access publication model that enables the dissemination of research articles to the global community free of cost. All the articles are distributed in any digital medium for the responsible purpose, possess subject to proper attribution of authorship and right to make small number of printed copies for the authorâs personal use. Biosafety journal is also involved in publishing the articles which are related to biological invasions, transgenic organisms, biological diversity, application of chemicals and new biotechniques for the disease control and human health. All the articles may be published as review/mini-review/ research article/ case reports/ letter to editors etc. Biosafety journal addresses the study of ecology, agriculture, medicine, chemistry and exobiology.
Last date updated on March, 2021